Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Mol Cell Cardiol. 2011 Oct;51(4):501-5. doi: 10.1016/j.yjmcc.2011.06.016. Epub 2011 Jun 28.

Neuregulin-1β for the treatment of systolic heart failure.

Author information

  • 1Cardiovascular Division, Department of Medicine, Vanderbilt University Medical School, Nashville, TN, USA. Douglas.b.sawyer@vanderbilt.edu

Abstract

The Neuregulin-1 gene encodes a family of ligands that act through the ErbB family of receptor tyrosine kinases to regulate morphogenesis of many tissues. Work in isolated cardiac cells as well as genetically altered mice demonstrates that neuregulin-1/ErbB signaling is a paracrine signaling system that functions in endocardial-endothelial/cardiomyocyte interactions to regulate tissue organization during development as well as maintain cardiac function throughout life. Treatment of animals with cardiac dysfunction with recombinant neuregulin-1beta improves cardiac function. This has led to ongoing early phase clinical studies examining neuregulin-1beta as a potential novel therapeutic for heart failure. In this review we synthesize the literature behind this rapidly evolving area of translational research. This article is part of a special issue entitled "Key Signaling Molecules in Hypertrophy and Heart Failure."

Copyright © 2011 Elsevier Ltd. All rights reserved.

PMID:
21729703
[PubMed - indexed for MEDLINE]
PMCID:
PMC3179893
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk